申请人:McCormick D. Kevin
公开号:US20070099872A1
公开(公告)日:2007-05-03
In its many embodiments, the present invention provides a novel class of indolines as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
在其许多实施方式中,本发明提供了一种新型的吲哚烷类化合物,作为α2C肾上腺素能受体激动剂的抑制剂,制备这种化合物的方法,含有一种或多种这种化合物的制药组合物,制备包含一种或多种这种化合物的制药制剂的方法,以及使用这种化合物或制药组合物的方法,用于治疗、预防、抑制或缓解与α2C肾上腺素能受体相关的一种或多种疾病。